Paroxysmal movement disorders

Neurologic Clinics

Volumn 33, Issue 1, 2015, Pages 137-152

  Waln, Olga ^a   Jankovic, Joseph ^b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Episodic ataxia; Paroxysmal choreoathetosis; Paroxysmal dyskinesia; Paroxysmal dystonia

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; GLUCOSE TRANSPORTER 1; HALOPERIDOL; LAMOTRIGINE; LEVODOPA; TETRABENAZINE; TOPIRAMATE;

ARTICLE; ATAXIA; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; BRAIN DEPTH STIMULATION; CHOREOATHETOSIS; DIFFERENTIAL DIAGNOSIS; DYSKINESIA; DYSTONIA; EPIDEMIOLOGY; EPISODIC ATAXIA; GASTROESOPHAGEAL REFLUX; GENE MUTATION; GENETIC DISORDER; HUMAN; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; OXIDATIVE STRESS; PAROXYSMAL CHOREOATHETOSIS; PAROXYSMAL DYSKINESIA; PAROXYSMAL DYSTONIA; PAROXYSMAL KINESIGENIC DYSKINESIA; PAROXYSMAL MOVEMENT DISORDER; PATHOPHYSIOLOGY; PROGRESSIVE SUPRANUCLEAR PALSY; SPASTIC PARAPLEGIA; COMPLICATION; DYSKINESIAS;

DYSKINESIAS; HUMANS; MOVEMENT DISORDERS;

EID: 84918508045     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2014.09.014     Document Type: Review

References (111)

1. Mount LA, Reback S. Familial paroxysmal choreoathetosis: preliminary report on a hitherto undescribed clinical syndrome. Arch Neurol Psychiatry 1940;44: 841-7.
2. Kertesz A. Paroxysmal kinesigenic choreoathetosis: an entity within paroxysmal choreoathetosis syndrome. Description of ten cases including one autopsied. Neurology 1967;17:680-90.
3. Lance JW. Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol 1977;2:285-93.
4. Lugaresi E, Cirignotta F. Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome? Sleep 1981;4:129-38.
5. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571-9.
6. Bruno MK, Hallett M, Gwinn-Hardy K, et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 2004; 63:2280-7.
7. Tan LC, Methawasin K, Teng EW, et al. Clinico-genetic comparisons of paroxysmal kinesigenic dyskinesia patients with and without PRRT2 mutations. Eur J Neurol 2014;21(4):674-8.
8. Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol 2014;13:100-12.
9. Tomita H, Nagamitsu S, Wakui K, et al. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am J Hum Genet 1999;65:1688-97.
10. Torisu H, Watanabe K, Shimojima K, et al. Girl with a PRRT2 mutation and infantile focal epilepsy with bilateral spikes. Brain Dev 2014;36(4):342-5.
11. Lee HY, Huang Y, Bruneau N, et al. Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012; 1(1):2-12.
12. Schmidt A, Kumar KR, Redyk K, et al. Two faces of the same coin: benign familial infantile seizures and paroxysmal kinesigenic dyskinesia caused by PRRT2 mutations. Arch Neurol 2012;69:668-70.
13. Szepetowski P, Rochette J, Berquin P, et al. Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997;61:889-98.
14. Marini C, Conti V, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 2012;79(21): 2109-14.
15. Erro R, Sheerin UM, Bhatia KP. Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification. Mov Disord 2014;29(9): 1108-16.
16. Cloarec R, Bruneau N, Rudolf G, et al. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology 2012;79(21):2097-103.
17. Dale RC, Gardiner A, Antony J, et al. Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol 2012;54(10):958-60.
18. Castiglioni C, López I, Riant F, et al. PRRT2 mutation causes paroxysmal kinesigenic dyskinesia and hemiplegic migraine in monozygotic twins. Eur J Paediatr Neurol 2013;17(3):254-8.
19. Riant F, Roze E, Barbance C, et al. PRRT2 mutations cause hemiplegic migraine. Neurology 2012;79(21):2122-4.
20. Fabbri M, Marini C, Bisulli F, et al. Clinical and polygraphic study of familial paroxysmal kinesigenic dyskinesia with PRRT2 mutation. Epileptic Disord 2013;15(2):123-7.
21. Wang JL, Cao L, Li XH, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 2011;134(Pt 12):3493-501.
22. Meneret A, Grabli D, Depienne C, et al. PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population. Neurology 2012;79(2):170-4.
23. Liu XR, Wu M, He N, et al. Novel PRRT2 mutations in paroxysmal dyskinesia patients with variant inheritance and phenotypes. Genes Brain Behav 2013;12(2): 234-40.
24. Hedera P, Xiao J, Puschmann A, et al. Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia.BMCNeurol 2012;12:93.
25. Steinlein OK, Villain M, Korenke C. The PRRT2 mutation c.649dupC is the so far most frequent cause of benign familial infantile convulsions. Seizure 2012;21(9): 740-2.
26. Méneret A, Gaudebout C, Riant F, et al. PRRT2 mutations and paroxysmal disorders. Eur J Neurol 2013;20(6):872-8.
27. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28(7):863-73.
28. Friedman J, Olvera J, Silhavy JL, et al. Mild paroxysmal kinesigenic dyskinesia caused by PRRT2 missense mutation with reduced penetrance. Neurology 2012;79(9):946-8.
29. van Vliet R, Breedveld G, de Rijk-van Andel J, et al. PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions. Neurology 2012;79(8):777-84.
30. Guerrini R, Mink JW. Paroxysmal disorders associated with PRRT2 mutations shake up expectations on ion channel genes. Neurology 2012;79(21):2086-8.
31. Shi CH, Sun SL, Wang JL, et al. PRRT2 gene mutations in familial and sporadic paroxysmal kinesigenic dyskinesia cases. Mov Disord 2013;28(9):1313-4.
32. Valente EM, Spacey SD, Wali GM, et al. A second paroxysmal kinesigenic choreoathetosis locus (EKD2) mapping on 16q13-q22.1 indicates a family of genes which give rise to paroxysmal disorders on human chromosome 16. Brain 2000; 123:2040-5.
33. Spacey SD, Valente EM, Wali GM, et al. Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: evidence for a third EKD gene. Mov Disord 2002;17:717-25.
34. Mao CY, Shi CH, Song B, et al. Genotype-phenotype correlation in a cohort of paroxysmal kinesigenic dyskinesia cases. J Neurol Sci 2014;340(1-2):91-3.
35. Bruno MK, Lee HY, Auburger GW, et al. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 2007;68:1782-9.
36. Auburger G, Ratzlaff T, Lunkes A, et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 1996;31(1):90-4.
37. Weber YG, Kamm C, Suls A, et al. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 2011;77(10):959-64.
38. Lee HY, Xu Y, Huang Y, et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004;13(24):3161-70.
39. Ghezzi D, Viscomi C, Ferlini A, et al. Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. Hum Mol Genet 2009;18(6):1058-64.
40. Shen Y, Lee HY, Rawson J, et al. Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability. Hum Mol Genet 2011;20(12):2322-32.
41. Du W, Bautista JF, Yang H, et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet 2005;37:733-8.
42. Spacey SD, Adams PJ, Lam PC, et al. Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia. Neurology 2006;66(10):1588-90.
43. Weber YG, Storch A, Wuttke TV, et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008;118(6):2157-68.
44. Yang H, Wang D, Engelstad K, et al. Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol 2011;70:996-1005.
45. Leen WG, Wevers RA, Kamsteeg EJ, et al. Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review. JAMA Neurol 2013;70(11):1440-4.
46. Dale RC, Melchers A, Fung VS, et al. Familial paroxysmal exercise-induced dystonia: atypical presentation of autosomal dominant GTP-cyclohydrolase 1 deficiency. Dev Med Child Neurol 2010;52(6):583-6.
47. Wu LJ, Jankovic J. Runner's dystonia. J Neurol Sci 2006;251:73-6.
48. Katz M, Byl NN, San Luciano M, et al. Focal task-specific lower extremity dystonia associated with intense repetitive exercise: a case series. Parkinsonism Relat Disord 2013;19(11):1033-8 pii:S1353-8020(13) 00267-8.
49. Kinast M, Erenberg G, Rothner AD. Paroxysmal choreoathetosis: report of five cases and review of the literature. Pediatrics 1980;65(1):74-7.
50. Provini F, Plazzi G, Lugaresi E. From nocturnal paroxysmal dystonia to nocturnal frontal lobe epilepsy. Clin Neurophysiol 2000;111(Suppl 2):S2-8.
51. Tinuper P, Cerullo A, Cirignotta F, et al. Nocturnal paroxysmal dystonia with short-lasting attacks: three cases with evidence for an epileptic frontal lobe origin of seizures. Epilepsia 1990;31(5):549-56.
52. Van Rootselaar AF, van Westrum SS, Velis DN, et al. The paroxysmal dyskinesias. Pract Neurol 2009;9:102-9.
53. Steinlein OK, Mulley JC, Propping P, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995;11(2):201-3.
54. De Fusco M, Becchetti A, Patrignani A, et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000;26(3): 275-6.
55. Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord 2002a; 17(4):726-34.
56. Blakeley J, Jankovic J. Secondary causes of paroxysmal dyskinesias. Adv Neurol 2002b;89:401-20.
57. De Seze J, Stojkovic T, Destée M, et al. Paroxysmal kinesigenic choreoathetosis as a presenting symptom of multiple sclerosis. J Neurol 2000;247(6):478-80.
58. Sethi KD, Lee KH, Deuskar V, et al. Orthostatic paroxysmal dystonia. Mov Disord 2002;17(4):841-5.
59. Baik JS, Lee MS. Movement disorders associated with moyamoya disease: a report of 4 new cases and a review of literatures. Mov Disord 2010;25(10): 1482-6.
60. Adam AM, Orinda DO. Focal paroxysmal kinesigenic choreoathetosis preceding the development of Steele-Richardson-Olszewski syndrome. J Neurol Neurosurg Psychiatr 1986;49(8):957-9.
61. Micheli F, Fernandez Pardal MM, Casas Parera I, et al. Sporadic paroxysmal dystonic choreoathetosis associated with basal ganglia calcifications. Ann Neurol 1986;20(6):750.
62. Tschopp L, Raina G, Salazar Z, et al. Neuroacanthocytosis and carbamazepine responsive paroxysmal dyskinesias. Parkinsonism Relat Disord 2008;14(5):440-2.
63. Bozi M, Bhatia KP. Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease. Mov Disord 2003;18(12):1545-7.
64. Mirsattari SM, Berry ME, Holden JK, et al. Paroxysmal dyskinesias in patients with HIV infection. Neurology 1999;52(1):109-14.
65. Ondo WG, Verma A. Physiological assessment of paroxysmal dystonia secondary to subacute sclerosing panencephalitis. Mov Disord 2002;17(1):154-7.
66. Micheli F, Tschopp L, Cersosimo MG. Oxcarbazepine-responsive paroxysmal kinesigenic dyskinesia in Wilson disease. Clin Neuropharmacol 2011;34(6):262-4.
67. Engelen M, Tijssen MA. Paroxysmal non-kinesigenic dyskinesia in antiphospholipid syndrome. Mov Disord 2005;20(1):111-3.
68. Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord 2012;27(8):935-46.
69. Dale RC, Heyman I, Surtees RA, et al. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child 2004;89(7):604-10.
70. Aradillas E, Schwartzman RJ. Kinesigenic dyskinesia in a case of voltage-gated potassium channel-complex protein antibody encephalitis. Arch Neurol 2011; 68(4):529-32.
71. Hall DA, Parsons J, Benke T. Paroxysmal nonkinesigenic dystonia and celiac disease. Mov Disord 2007;22(5):708-10.
72. Alonso-Navarro H, Arroyo M, Parra A, et al. Paroxysmal dystonia associated to primary Sjögren's syndrome. Mov Disord 2009;24(5):788-90.
73. Liu MY, Zhang SQ, Hao Y, et al. Paroxysmal kinesigenic dyskinesia as the initial symptom of Hashimoto encephalopathy. CNS Neurosci Ther 2012;18:271-3.
74. Rosen JA. Paroxysmal choreoathetosis associated with perinatal hypoxic encephalopathy. Arch Neurol 1964;11:385-7.
75. Fahn S, Jankovic J, Hallett M. The paroxysmal dyskinesias. In: Fahn S, Jankovic J, Hallett M, editors. Principles and practice of movement disorders. 2nd edition. Philadelphia: Elsevier Sanders; 2011. p. 476-95.
76. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994;8(2):136-40.
77. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca21 channel gene CACNL1A4. Cell 1996;87(3):543-52.
78. Cader MZ, Steckley JL, Dyment DA, et al. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology 2005;65(1):156-8.
79. Farmer T, Mustian VM. Vestibulo-cerebellar ataxia: a newly defined hereditary syndrome with periodic manifestations. Arch Neurol 1963;8:471-80.
80. Escayg A, De Waard M, Lee DD, et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000;66(5):1531-9.
81. Jen JC, Wan J, Howard BD, et al. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005;65(4):529-34.
82. Kerber KA, Jen JC, Lee H, et al. A new episodic ataxia syndrome with linkage to chromosome 19q13. Arch Neurol 2007;64(5):749-52.
83. Conroy J, McGettigan P, Murphy R, et al. A novel locus for episodic ataxia: UBR4 the likely candidate. Eur J Hum Genet 2014;22:505-10.
84. Fernandez M, Raskind W, Wolff J, et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder. Ann Neurol 2001;49:486-92.
85. Chen YZ, Matsushita MM, Robertson P, et al. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. Arch Neurol 2012;69:630-5.
86. Chen YZ, Friedman JR, Chen DH, et al. Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol 2014;75(4):542-9.
87. Snyder CH. Paroxysmal torticollis in infancy. A possible form of labyrinthitis. Am J Dis Child 1969;117(4):458-60.
88. Angelini L, Rumi V, Lamperti E, et al. Transient paroxysmal dystonia in infancy. Neuropediatrics 1988;19(4):171-4.
89. Verrotti A, Trotta D, Blasetti A, et al. Paroxysmal tonic upgaze of childhood: effect of age-of-onset on prognosis. Acta Paediatr 2001;90:1343-5.
90. Antony JH, Ouvrier RA, Wise G. Spasmus nutans: a mistaken identity. Arch Neurol 1980;37:373-5.
91. Dill P, Wagner M, Somerville A, et al. Child neurology: paroxysmal stiffening, upward gaze, and hypotonia: hallmarks of sepiapterin reductase deficiency. Neurology 2012;78(5):e29-32.
92. van Strien TW, van Rootselaar AF, Hilgevoord AA, et al. Paroxysmal kinesigenic dyskinesia: cortical or non-cortical origin. Parkinsonism Relat Disord 2012;18(5): 645-8.
93. Lombroso CT. Paroxysmal choreoathetosis: an epileptic or non-epileptic disorder? Ital J Neurol Sci 1995;16(5):271-7.
94. Loong SC, Ong YY. Paroxysmal kinesigenic choreoathetosis. Report of a case relieved by L-dopa. J Neurol Neurosurg Psychiatr 1973;31:921-4.
95. Ko CH, Kong CK, Ngai WT, et al. Ictal (99m) Tc ECD SPECT in paroxysmal kinesigenic choreoathetosis. Pediatr Neurol 2001;24:225-7.
96. Joo EY, Hong SB, Tae WS, et al. Perfusion abnormality of the caudate nucleus in patients with paroxysmal kinesigenic choreoathetosis. Eur J Nucl Med Mol Imaging 2005;32:1205-9.
97. Kluge A, Kettner B, Zschenderlein R, et al. Changes in perfusion pattern using ECD-SPECT indicate frontal lobe and cerebellar involvement in exerciseinduced paroxysmal dystonia. Mov Disord 1998;13(1):125-34.
98. Lee HY, Nakayama J, Xu Y, et al. Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia. J Clin Invest 2012;122(2):507-18.
99. Sohn YH, Lee PH. Paroxysmal choreodystonic disorders. Handb Clin Neurol 2011;100:367-73.
100. Margari L, Presicci A, Ventura P, et al. Channelopathy: hypothesis of a common pathophysiologic mechanism in different forms of paroxysmal dyskinesia. Pediatr Neurol 2005;32(4):229-35.
101. Winkler AS, Friedrich K, König R, et al. The head nodding syndrome-clinical classification and possible causes. Epilepsia 2008;49(12):2008-15.
102. Ganos C, Aguirregomozcorta M, Batla A, et al. Psychogenic paroxysmal movement disorders - clinical features and diagnostic clues. Parkinsonism Relat -Disord 2014;20:41-6.
103. Bakker MJ, van Dijk JG, van den Maagdenberg AM, et al. Startle syndromes. Lancet Neurol 2006;5(6):513-24.
104. Bakker MJ, van Dijk JG, Pramono A, et al. Latah: an Indonesian startle syndrome. Mov Disord 2013;28(3):370-9.
105. Kirkham FJ, Haywood P, Kashyape P, et al. Movement disorder emergencies in childhood. Eur J Paediatr Neurol 2011;15(5):390-404.
106. Bhatia KP. Paroxysmal dyskinesias. Mov Disord 2011;26(6):1157-65.
107. Mehta SH, Morgan JC, Sethi KD. Paroxysmal dyskinesias. Curr Treat Options Neurol 2009;11:170-8.
108. Loher TJ, Krauss JK, Burgunder JM, et al. Chronic thalamic stimulation for treatment of dystonic paroxysmal nonkinesigenic dyskinesia. Neurology 2001;56(2): 268-70.
109. Kaufman CB, Mink JW, Schwalb JM. Bilateral deep brain stimulation for treatment of medically refractory paroxysmal nonkinesigenic dyskinesia. J Neurosurg 2010;112(4):847-50.
110. Alter AS, Engelstad K, Hinton VJ, et al. Long-term clinical course of Glut1 deficiency syndrome. J Child Neurol 2014. [Epub ahead of print].
111. Strupp M, Kalla R, Claassen J, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 2011;77(3):269-75.